Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy.
Ho TC, Kim HS, Chen Y, Li Y, LaMere MW, Chen C, Wang H, Gong J, Palumbo CD, Ashton JM, Kim HW, Xu Q, Becker MW, Leong KW.
Ho TC, et al. Among authors: xu q.
Sci Adv. 2021 May 19;7(21):eabg3217. doi: 10.1126/sciadv.abg3217. Print 2021 May.
Sci Adv. 2021.
PMID: 34138728
Free PMC article.